FDA OKs Dostarlimab Plus Chemo for Endometrial Cancer : comp

The approval moves dostarlimab's endometrial cancer indication earlier in the treatment paradigm.

Related Keywords

Hesham Abdullah , Glaxosmithkline , Drug Administration , Rxdx Panel , Endometrial Carcinoma , Cancer , Alignant Neoplasia , Arcinoma , Reproductive Health , Drug Development , Womens Health , Reproductive Endocrinology , Chemotherapy , Toxicology , Combination Chemotherapy , Hypothyroidism , Microsatellite Instability High , Micro Satellite Instability High , Msi H , Microsatellite Instability , Si , Tumor , Diarrhea , Colitis , Us Food And Drug A ,